Certified by Founder
Lodge
Trogenix
start up

- 07/10/2025
- Series A
- $94,323,600
Precision genetic medicines, engineered for change
- Industry Biotechnology Research
- Website https://trogenix.com/
- LinkedIn https://www.linkedin.com/company/trogenixbio/
Related People
Ken MacnamaraFounder

Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.